To provide more insight into the clinical significance of MAP3K1 expression in gliomas, we examined the MAP3K1 expression in glioma tissue from patients with varying survival outcomes, such as OS and disease‐free interval (DFI), using data from TCGA. The gene discussed is MAP3K1; the disease is glioma.